Fiducial Company Profile

04:06 EDT 20th March 2018 | BioPortfolio

Since entering the U.S. market in 1999, Fiducial has become the largest network of professional services advisors in the nation with annual revenues of nearly $100 million, ranking them nineteenth among the country's top accounting firms. Today in the U.S., Fiducial now serves clients nationwide through a network of more than 375 company-owned and franchise offices.After establishing a firm foothold in the U.S., Fiducial continues to develop its franchise network by growing its team in charge of franchise sales and increasing its advertising power. Fiducial is also targeting about four new franchisees every month. In this market, Fiducial doesn't have any strong competitor. Spurring this growth has been the rising demands of thousands of small businesses in the U.S. that are turning to Fiducial to file their tax returns, provide them with monthly financial reports, payroll systems and business counseling. There are about 11.3 million businesses with 100 employees or less in the U.S. which typically can't afford to have a different consultant or advisor for each separate function the way large companies can.Unique in its ability to provide business services to small businesses and individuals at a very reasonable monthly fee, Fiducial is unsurpassed in its network of offering nationally its depth of experience and expertise, its financial strength and its national brand.


10480 Little Patuxent Parkway, Third Floor
United States of America


Fax: (410) 910-5903

News Articles [0 Results]


Drugs and Medications [0 Results]


PubMed Articles [16 Associated PubMed Articles listed on BioPortfolio]

Quantification of MRI visibility and artefacts at 3T of liquid fiducial marker in a pancreas tissue mimicking phantom.

X-ray based position verification of the target volume in image-guided radiation therapy (IGRT) of patients with pancreatic ductal adenocarcinoma (PDAC) is currently performed on solid fiducial marker...

Proton Beam Therapy without Fiducial Markers Using Four-Dimensional CT Planning for Large Hepatocellular Carcinomas.

We evaluated the effectiveness and toxicity of proton beam therapy (PBT) for hepatocellular carcinomas (HCC) >5 cm without fiducial markers using four-dimensional CT (4D-CT) planning. The subjects wer...

Computed tomography based evaluation of prostatic fiducial marker migration between the periods of insertion and simulation.

The aim of this study was to determine whether significant fiducial marker migration occurs between the periods of prostatic marker insertion and computed tomography (CT) performed for radiotherapy pl...

Respiratory-gated Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract without Fiducial Markers.

The efficacy of proton beam therapy (PBT) for hepatocellular carcinoma (HCC) has been reported, but insertion of fiducial markers in the liver is usually required. We evaluated the efficacy and toxici...

Intramural duodenal hematoma post EUS-guided placement of fiducial radiopaque markers.

Clinical Trials [23 Associated Clinical Trials listed on BioPortfolio]

Endoscopic Ultrasound-Guided Fiducial Placement for Stereotactic Body Radiotherapy

The purpose of this research study is to evaluate placing the radiation therapy markers (Fiducial) by using an endoscopic procedure. The endoscopic procedure is called an Endoscopic Ultra...

EUS Fiducial for Pancreas Surgery

RATIONALE: Pancreas tumor localization makes minimally invasive surgical resection of pancreas tumors very challenging. Recently, an endoscopic ultrasound needle system has been developed ...

Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy

Primary Objective: - To collect data on the distribution among patients of the difference in location of the prostate relative to the isocenter as determined by two methods: ...

BioXmark, Rectal Feasibility Trial

To test the feasibility and accuracy of BioXmark fiducial markers for image guided radiotherapy (IGRT) based rectal tumor boosting in 20 patients referred for long course chemo-radiotherap...

Feasibility Study of Fiducial Markers in Oesophageal Cancer

Currently, patients of suitable fitness with non-metastatic esophageal cancer are treated with surgery, radiotherapy or chemoradiotherapy. If treated with radio or chemoradiotherapy, a Com...

Companies [1 Associated Companies listed on BioPortfolio]


Since entering the U.S. market in 1999, Fiducial has become the largest network of professional services advisors in the nation with annual revenues of nearly $100 million, ranking them nineteenth amo...

More Information about "Fiducial" on BioPortfolio

We have published hundreds of Fiducial news stories on BioPortfolio along with dozens of Fiducial Clinical Trials and PubMed Articles about Fiducial for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fiducial Companies in our database. You can also find out about relevant Fiducial Drugs and Medications on this site too.

Quick Search


Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record